INC Research Establishes Site Advocacy Group to Improve Investigator Payments
INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS).
INC Research announced the formation of a new Site Advocacy Group (SAG) under the auspices of its relationship with the Society for Clinical Research Sites (SCRS). The Investigator Payment SAG, which will kick-off later this year, was established in response to specific feedback from sites that noted financial challenges to their ongoing sustainability as a participant in the clinical research enterprise. The Investigator Payment SAG aims to understand in depth the pain points sites experience and modernize financial processes to keep clinical research sites engaged, as well as recruit new sites.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
